Revenue segments as reported by the company.

Premiums

Products

Services

Investment and other income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Medical costs

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

UnitedHealth Group

Optum is a Health Services platform. It is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities.

Optum

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

UnitedHealth Group reports strong Q4 earnings and growth opportunities

UnitedHealth Group's Q4 2022 Earnings Call highlighted strong financial performance, growth initiatives, and confidence in sustainable earnings growth. The company is focused on enhancing consumer experiences, expanding value-based care, and driving growth through strategic investments and M&A priorities. Challenges include managing cost impacts from flu and respiratory issues, while opportunities lie in continued growth in key segments and strategic M&A.

UnitedHealth Group reports robust Q1 earnings, eyes growth opportunities

UnitedHealth Group's strong performance in Q1 2023 reflects growth across its segments, driven by a focus on value-based care and consumer-centric initiatives. While challenges exist with potential Medicare Advantage model changes, the company remains optimistic about sustained growth and opportunities for expansion.

UnitedHealth Group posts robust Q2 earnings, eyes tech-driven growth

UnitedHealth Group delivered strong financial performance in Q2 2023, with a focus on expanding patient care, driving cost efficiencies, and responding to changing healthcare dynamics. Challenges include margin pressures and managing investment gains unpredictability. Opportunities lie in leveraging technology for cost reduction and enhancing care capabilities post acquisitions.

UnitedHealth Group reports robust Q3 growth, eyes expansion in value-based care

UnitedHealth Group's Q3 performance showcased robust revenue growth and strengthened earnings outlook. The company's focus on value-based care, strong performance in pharmacy services, and investments in home care present opportunities for future growth. However, challenges related to wage inflation and margin impact at Optum Health require attention.

UnitedHealth Group posts strong 2023 results, eyes growth opportunities

UnitedHealth Group's 2023 performance showcased robust financial results, strategic investments in digital engagement, and a focus on improving healthcare quality and accessibility. While facing challenges in cost trends and industry dynamics, the company remains optimistic about its competitive positioning and growth prospects in 2024.

UnitedHealth Group resilient post-cyberattack, eyes growth opportunities

UnitedHealth Group navigated cyberattack impacts while maintaining outlook.
Strong response to challenges, focusing on growth and customer support.
Balanced approach to capital deployment and confidence in future opportunities.
Optimism in controlling costs and driving growth through innovation.

UnitedHealth Group reports resilient growth amidst cyberattack challenges

UnitedHealth Group's Q2 2024 performance reflects resilience and growth potential despite challenges from a cyberattack and other disruptions.
The company's strengths in customer recognition, Medicare Advantage programs, and technology innovation position it well for future success and market expansion.
While facing challenges like cyberattack impacts and medical care ratio issues, UnitedHealth Group remains focused on opportunities for growth and returning to baseline performance in 2025.

UnitedHealth Group affirms growth outlook amidst challenges, eyes 2025 strategy

UnitedHealth Group's Q3 2024 performance reflects strong revenue growth and a commitment to value-based care and innovation. Despite challenges like cyberattacks and care patterns impacting earnings outlook, the company remains focused on long-term growth objectives. UNH's strategic investments, focus on consumer experience, and capital deployment priorities signal a proactive approach to driving future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Amazon

Caterpillar

Chevron

Johnson & Johnson

Merck

Sherwin-Williams

The year 2024 saw the U.S. stock market make new records, with major indices breaching key milestones. While many stocks witnessed a stellar rally this year, analysts still expect some blue-chip equities to rise further as they forecast a better return potential.

Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025

Panic sellers have bailed out of UnitedHealth stock as the leading healthcare sector leader took a significant hammering. Despite structural headwinds, UNH's diversified business model, particularly its profitable Optum segment, underpins its solid profitability and positions it well against smaller peers. UNH's valuation has dropped below its 10-year average, making it reasonably valued and an attractive opportunity for aggressive dip-buying.

UnitedHealth: Don't Let The Market Fool You

UnitedHealth Group (UNH) closed the most recent trading day at $506.10, moving -0.05% from the previous trading session.

UnitedHealth Group (UNH) Stock Falls Amid Market Uptick: What Investors Need to Know

The latest trading day saw UnitedHealth Group (UNH) settling at $506.34, representing a +1.24% change from its previous close.

Why UnitedHealth Group (UNH) Outpaced the Stock Market Today

UnitedHealth Group's recent price pullback presents a buying opportunity for long-term dividend growth investors, despite the CEO's death and short-term volatility. Strong fundamentals: Q3 earnings beat estimates with EPS of $7.15 and revenue at $100.8 billion, showing robust top and bottom line growth. Sustainable dividend growth: Dividend increased by 11.70%, supported by strong cash flows and a solid balance sheet with $32.4 billion in cash.

UnitedHealth Group: Recent Pullback Is A Buying Opportunity For Dividend Growth Investors (Rating Upgrade)

UnitedHealth Group (UNH) shares have been on the decline since the CEO of its UnitedHealthcare unit was killed in New York City on Dec. 4.

UnitedHealth Stock Price Levels to Watch After Extended Sell-Off

Amgen

Salesforce

Goldman Sachs

Home Depot

NVIDIA

Travelers

Investors seemed to shrug off the meltdown on Thursday. Some Dow Jones laggards of this period tried to rebound as well.

10 Biggest Losers of The Dow Jones Index's 10-Day Losing Streak

IAC/InterActiveCorp

MGM Resorts

UnitedHealth Group shares have dropped over 20% due to public backlash and political rhetoric; current valuation suggests 17-30% upside potential. IAC remains undervalued in a SOTP framework, with MGM Resorts presenting significant upside due to its clean balance sheet and undervalued core US gaming business. MGM's US gaming business is undervalued at ~9x free cash flow; fair value suggests 25-43% upside when considering its Chinese business stake.

Tax Loss Selling, Three (More) Oversold Stocks

UNH faces challenges such as rising medical costs and regulatory pressures. However, it boasts robust cash flow and consistent dividend growth.

UnitedHealth Stock Down 15.9% in 3 Months: Should You Hold or Fold?

The stock price of the health insurer has tumbled 21% since a top executive was murdered on Dec. 4.

UnitedHealth Is Dragging Down the Dow. It's an Overreaction.

The U.S.' bluechip stock index is on the cusp of suffering its longest stretch in the red since 1978, a potentially concerning signal for investors enjoying an otherwise sanguine period for stocks, though Tuesday's losses are largely tied to a singular company—UnitedHealth Group—and gains remain healthy over a longer timeframe.

Dow Heads To Worst Losing Streak In Nearly 50 Years—This Stock Is Driving Index Down

Cigna

CVS Health

Shares in major healthcare companies fell yesterday after president-elect Donald Trump made comments that he wanted to “knock out” prescription drug industry middlemen. The fall makes this yet another week since the killing of UnitedHealth CEO Brian Thompson that the business practices of companies that operate America's private healthcare system have come under increased scrutiny.

UnitedHealth, CVS, and Cigna stock prices take another hit after Trump says he's going to ‘knock out' drug industry middlemen

Eli Lilly

Pfizer

Shares of health insurers operating pharmacy benefit managers fell on Monday after U.S. President-elect Donald Trump called them middlemen who drive up costs and said he plans to eliminate their role.

Insurer stocks fall after Trump says 'we're going to knock out the middleman'

Three new companies joining the Watchlist, including ServiceNow and Sterling Infrastructure, hold very good IBD ratings. The post Growth Stocks To Buy For The Long Term: Will UnitedHealth Remain A Long-Term Leader?

Growth Stocks To Buy For The Long Term: Will UnitedHealth Remain A Long-Term Leader?

The healthcare system needs to work better to defuse Americans' frustrations and address their medical needs, UnitedHealth Group CEO Andrew Witty said Friday, addressing the resentment with health insurance that surfaced after the murder of a top executive in his company.

UnitedHealth Group CEO says healthcare needs fixing. Start with these 3 problems in claims and patient costs, experts say.

--(BUSINESS WIRE)--UnitedHealth Group today issued the following update: Claims approval rates UnitedHealthcare approves and pays about 90% of medical claims upon submission. Importantly, of those that require further review, around one-half of one percent are due to medical or clinical reasons. Highly inaccurate and grossly misleading information has been circulated about our company's treatment of insurance claims. Whether the killer and his parents were UnitedHealthcare members Regarding the.

Media Advisory: UnitedHealth Group Responds to Misinformation

UnitedHealth Group CEO Andrew Witty wrote in an op-ed that the company wants to continue to push for health care industry reforms following the killing of Brian Thompson.

UnitedHealth Group CEO argues for health care reform in op-ed

Andrew Witty reacted on Friday to the deluge of social media posts celebrating the Dec. 4 killing of Thompson in Midtown Manhattan.

UnitedHealth Group CEO admits ‘system is flawed' after Brian Thompson's murder

UnitedHealth Group CEO Andrew Witty mourned the death of Brian Thompson, who led the company's insurance arm, and acknowledged that the U.S. healthcare system is "flawed" and in need of reform.  In a New York Times opinion pieces, Witty made his first public comments since last week's fatal shooting of Thompson.

UnitedHealth Group CEO addresses Brian Thompson death, says healthcare system is 'flawed'

CEO Andrew Witty said: "We know the health system does not work as well as it should, and we understand people's frustrations with it."

UnitedHealth CEO Talks About Brian Thompson Death for First Time. Calls for Reforms.

One of the most publicized stories of the year has been the murder of UnitedHealth Group (NYSE: UNH) medical insurance division CEO Brian Thompson.

UnitedHealth Group stock slumps to 5-month low; What's next?

UnitedHealth's chief executive on Friday called for the healthcare system to be overhauled, following the emotional and angry reaction many had to the murder of one of the company's senior executives.

UnitedHealth stock has plunged since Brian Thompson's murder. The CEO now is calling for healthcare reform.

UnitedHealth Group CEO Andrew Witty wrote in a New York Times opinion piece on Friday that the healthcare system was flawed and was a "patchwork built over decades."

UnitedHealth Group CEO Andrew Witty says healthcare system is flawed

UnitedHealth stock is continuing to fall Thursday after the introduction of bipartisan legislation targeting PBMs and healthcare giants. Here's what to know.

UnitedHealth Stock Falls as Lawmakers Eye Insurers, PBMs

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

News for UnitedHealth Group Stock (UNH)